Last reviewed · How we verify
NCT07498192
Thai Baby Study Phase 1
trial in Outcome Assessment in 10,300 participants. Not yet recruiting.
30 May 2026
Quick facts
| Lead sponsor | Mead Johnson Nutrition |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 10,300 |
| Start date | 1 March 2026 |
| Primary completion | 30 May 2026 |
| Estimated completion | 31 December 2026 |
Conditions studied
- Outcome Assessment — all drugs for Outcome Assessment →
Sponsor
Mead Johnson Nutrition — full company profile →
Who can join
Under 120, any sex, with Outcome Assessment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to examine national trends in mode of delivery and to assess associations between cesarean section and early-life health outcomes using routinely collected health data in Thailand. The study includes mother-infant dyads delivering in public hospitals across Thailand. The main questions it aims to answer are: Is cesarean delivery associated with increased risk of adverse neonatal outcomes compared with vaginal delivery? Is cesarean delivery associated with differences in early-life healthcare utilization and breastfeeding outcomes during the first year of life? Researchers will compare infants born by cesarean section with infants born by vaginal delivery to evaluate differences in neonatal morbidity, healthcare utilization, and breastfeeding patterns. Participants will not receive any intervention. The study involves secondary analysis of de-identified national health administrative and clinical data, including delivery records and linked maternal and infant health outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07498192
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Outcome Assessment
Currently open trials in the same condition.
- NCT07329140 — Outcomes of Robotic-Assisted Urological Surgery · recruiting
- NCT06823466 — Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants · recruiting
- NCT05709457 — Long Term Effects Of a Maternal Cash Transfer Experiment · NA · active not recruiting
- NCT06959849 — Robot-assisted Surgery for Colorectal Cancer Resection: A Population-based Analysis of Prevalence, Trends and Outcomes · active not recruiting
Other Mead Johnson Nutrition trials
Trials by the same sponsor.
- NCT07513506 — Extensively Hydrolyzed Formula Growth Monitioring Study (GMS) · NA · not yet recruiting
- NCT06318117 — Reason for Prescribing Rice Infant Formula · completed
- NCT05744193 — Feeding Study in VLBW Premature Infants · NA · terminated
- NCT05247879 — Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution · NA · completed
- NCT05245422 — Acceptance of a Partially Hydrolyzed Formula · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07498192 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mead Johnson Nutrition
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07498192.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing